Clinical Evidence Behind Wegovy vs Mounjaro Dosing Protocols
Wegovy vs Mounjaro Dosage Chart: Weight Loss Results in UK Clinical Trials
When comparing Wegovy vs Mounjaro dosage charts, the weight loss results from UK and international clinical trials provide crucial evidence for informed decision-making. In the landmark STEP trials, patients taking Wegovy alongside diet and exercise achieved an average of ~clinically studied weight loss at 68 weeks, following the complete dose escalation from 0.25mg through to 2.4mg maintenance. The Wegovy dosage chart spans 17 weeks of gradual increases, whilst Mounjaro follows a different protocol with 12 weeks of escalation to its maximum 15mg dose. Both prescription-only medicines require careful clinical oversight, which is why our GPhC-registered pharmacy (#9012878) ensures proper prescriber review before dispensing either treatment.
The weight loss results from these dosage protocols demonstrate the importance of following the complete escalation schedule rather than attempting to reach maintenance doses quickly. Wegovy's five-step dosing (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg) allows for gradual adaptation, while Mounjaro's four-step approach (2.5mg, 5mg, 10mg, 15mg) uses a different timeline. Understanding these Wegovy vs Mounjaro dosage chart differences helps explain why trial participants achieved sustained weight loss results when adhering to the prescribed protocols alongside reduced-calorie diets and increased physical activity.
Wegovy vs Mounjaro Dosage Chart Pricing: Complete UK Cost Breakdown
The cost implications of following a complete Wegovy vs Mounjaro dosage chart require careful financial planning, as both medications represent significant investments in weight management. Our Wegovy pricing starts with the 0.25mg starter dose at £79.99, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to the maintenance 2.4mg at £209.99 per pen. New customers can apply discount code FIRST40 at checkout, while returning customers use DOSE25 to reach these final prices. For patients preferring bundled supply, our Getting Started bundles provide convenient dose progression—the Intro Duo (0.25mg & 0.5mg) costs £169.99, while the complete Intro Trio (0.25mg, 0.5mg & 1mg) is available for £299.99.
Mounjaro pricing follows a different structure due to its distinct dosage chart requirements, and both medications are available through our streamlined ordering process. The Wegovy vs Mounjaro dosage chart comparison shows that Wegovy requires five different pen strengths over 17 weeks, while Mounjaro uses four strengths over 12 weeks. Our bundle options accommodate both protocols—the Progress Trio (0.5mg, 1mg & 1.7mg Wegovy) costs £369.99, providing three months of progression, whilst our Ultimate Stability Trio offers three 2.4mg maintenance pens for £649.99. These pricing structures reflect the different approaches each medication takes to achieve optimal weight loss results.
Wegovy vs Mounjaro Dosage Chart Evidence: STEP Trial Weight Loss Data
The clinical evidence supporting Wegovy's dosage chart comes primarily from the comprehensive STEP trial programme, published by Wilding et al. in the New England Journal of Medicine, 2021. In STEP 1, patients following the complete Wegovy dosage chart achieved ~15% average weight loss at 68 weeks compared to ~2.4% with placebo. STEP 3 demonstrated that combining Wegovy's dose escalation with intensive behavioural therapy resulted in ~clinically studied weight loss, while STEP 5 showed sustained ~clinically studied weight loss at two years.
The recent SELECT cardiovascular outcomes trial revealed that patients following the Wegovy dosage chart experienced a 20% reduction in major cardiovascular events (hazard ratio 0.80), providing additional evidence beyond weight loss results. These trials consistently show that the gradual dose escalation protocol—from 0.25mg starter through to 2.4mg maintenance—optimises both efficacy and tolerability when combined with reduced-calorie diets and increased physical activity.
How Wegovy Works: GLP-1 Mechanism Behind the Dosage Chart
Understanding how Wegovy works explains why the specific dosage chart progression is crucial for achieving optimal weight loss results. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone released after eating. This mechanism reduces appetite by acting on brain centres that control hunger and satiety, helping patients feel fuller after smaller meals. The gradual dose escalation from 0.25mg to 2.4mg allows patients to adapt to these appetite changes while minimising potential side effects. Unlike Mounjaro, which targets both GIP and GLP-1 receptors as a dual agonist, Wegovy focuses specifically on GLP-1 pathways. The once-weekly injection schedule using the FlexTouch pen device supports long-term adherence throughout the 17-week escalation period.
Ordering Process: Accessing Wegovy vs Mounjaro Dosage Charts
Obtaining either medication through our Wegovy vs Mounjaro dosage chart consultation begins with a comprehensive 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Our qualified prescribers review each application within 24 hours for express service or 3 working days for standard processing, ensuring the chosen dosage protocol suits your individual circumstances. Once approved, we dispatch your medication via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) provides detailed dosing instructions, injection technique guidance, and ongoing support throughout your treatment journey. Both Wegovy and Mounjaro require prescription-only medicine status, meaning proper clinical oversight protects patient safety while ensuring optimal treatment outcomes.
Wegovy vs Mounjaro Dosage Chart Storage: Practical Differences
The storage requirements for Wegovy vs Mounjaro dosage chart medications reveal important practical differences that may influence your choice. Wegovy pens must be stored in the fridge at 2-8°C before first use but can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration. This provides significant flexibility for travel or daily use compared to Mounjaro, which only tolerates 21 days at room temperature after fridge removal. Each Wegovy FlexTouch pen contains four doses, administered once weekly, meaning a single pen lasts one month regardless of the dose strength. The dose escalation schedule requires different pen strengths—you cannot achieve higher doses by taking multiple injections of lower-strength pens. Proper storage throughout the 17-week progression ensures medication potency and treatment effectiveness.
UK Weight Loss Results: Real-World Wegovy vs Mounjaro Dosage Chart Outcomes
Real-world weight loss results in the UK reflect the clinical trial evidence supporting both Wegovy and Mounjaro dosage chart protocols, though individual outcomes vary significantly based on adherence, lifestyle factors, and baseline characteristics. The STEP trial data showing ~15% average weight loss at 68 weeks provides realistic expectations for patients following the complete Wegovy dose escalation alongside reduced-calorie diets and increased physical activity. UK patients accessing Wegovy through NICE TA875 recommendations typically receive specialist weight management support, which may enhance outcomes compared to clinical trials alone.
When comparing Wegovy vs Mounjaro dosage chart results, it's important to note that direct head-to-head trials are limited, and the medications work through different mechanisms—Wegovy as a GLP-1 receptor agonist versus Mounjaro as a dual GIP/GLP-1 agonist. Both medications are available from EverydayMeds, and your prescriber can help determine which dosage protocol aligns with your medical history, treatment goals, and lifestyle preferences. The key to achieving optimal weight loss results lies in completing the full dose escalation, maintaining consistent weekly injections, and combining medication with sustainable dietary and exercise modifications.
Start Your Wegovy vs Mounjaro Dosage Chart Journey Today
Beginning your weight loss journey with either Wegovy or Mounjaro requires careful consideration of the dosage chart differences, costs, and clinical evidence supporting each option. New customers can access Wegovy starting doses for £79.99 using discount code FIRST40, while returning customers apply code DOSE25 at checkout for the best available pricing. Our streamlined consultation process connects you with qualified prescribers who can evaluate which medication and dosing protocol suits your individual circumstances. Both Wegovy and Mounjaro are prescription-only medicines requiring proper clinical oversight, but our GPhC-registered pharmacy (#9012878) makes accessing treatment straightforward and convenient. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and take the first step towards evidence-based weight management with either Wegovy or Mounjaro dosage chart guidance.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
